Neurochemical Research

, Volume 22, Issue 4, pp 401–407 | Cite as

Autoradiographic Localization of the Putative D4 Dopamine Receptor in Rat Brain

  • M. Cristina Defagot
  • Marta C. Antonelli


The putative dopamine D4 receptor protein in rat brain was labelled and quantified autoradiographically using two selective benzamides: [3H]YM-09151-2 which labels D2, D3 and D4 dopamine receptors and [3H]Raclopride which labels D2 and D3. The difference in densities of both ligands at saturable concentrations, show a regional distribution for the putative D4 receptor in the following rank order: hippocampus > caudate putamen > olfactory tubercle = substancia nigra > nucleus accumbens core > cerebral cortex > cerebellum. A calculated value of 0.34 pmol/mg protein was attributable to D4 receptor maximum capacity in caudate putamen and was obtained after subtracting the Bmax of the ligands. Our results show that the distribution of D4 receptor only partially overlaps with the D4 mRNA localization reported earlier and is not only associated to limbic structures but to motor areas as well.

Dopamine D4 receptor quantitative autoradiography benzamides rat brain 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grandy, D. K., and Civelli, O. 1992. G-protein-coupled receptors: the new dopamine receptor subtypes. Curr. Op. Neurobiol. 2:275–281.Google Scholar
  2. 2.
    Sibley, D. R., and Monsma, F. J. 1992. Molecular biology of dopamine receptors. Trends. Pharmacol. Sci. 13:61–69.Google Scholar
  3. 3.
    O'Dowd, B. P. 1993. Structures of dopamine receptors. J. Neurochem. 60:804–816.Google Scholar
  4. 4.
    Civelli, O., Bunzow, J. R., and Grandy, D. K. 1993. Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 32:281–307.Google Scholar
  5. 5.
    Baldessarini, R. J., and Tarazi, F. I. 1996. Brain dopamine receptors: a primer on their current status, basic and clinical. Harvard Rev. Psychiatry 3:301–325.Google Scholar
  6. 6.
    Civelli, O. 1995. Molecular biology of the dopamine receptor subtypes. Pages 155–161, in Bloom, F. E., and Kupfer, D. J., (eds.), Psychopharmacology: The fourth generation of progress. Raven Press, Ltd., New York.Google Scholar
  7. 7.
    Van Tol, H. H. M., Bunzow, J. R., Guan, H-C., Sunahara, R. K., Seeman, P., Niznik, H. B., and Civelli, O. 1991. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350:610–614.Google Scholar
  8. 8.
    Lahti, R. A., Evans, D. L., Stratman, N. C., and Figur, L. M. 1993. Dopamine D4 versus dopamine D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. Eur. J. Pharmacol. 236:483–486.Google Scholar
  9. 9.
    Gingrich, J. A., and Caron, M. G. 1993. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16:299–321.Google Scholar
  10. 10.
    Kane, J., Honigfeld, G., Singer, J., Meltzer, H., and the Clozaril collaborative study group. 1988. Clozapine for the treatment-resistant schizophrenic. Arch. Gen. Psychiatry. 45:789–796.Google Scholar
  11. 11.
    Casey, D. E. 1989. Clozapine: neuroleptic-induced extrapyramidal side effects and tardive dyskinesia. Psychopharmacology Suppl. 99:S47-S53.Google Scholar
  12. 12.
    Seeman, P. 1995. Dopamine receptors. Clinical Correlates. Pages 295–302, in Bloom, F. E., and Kupfer, D. J., (eds.), Psychopharmacology: The fourth generation of progress. Raven Press, Ltd., New York.Google Scholar
  13. 13.
    Mansour, A., Meador-Woodruff, J., Burke, S., Bunzow, J., Akil, H., Van Tol, H. H. M., Civelli, O., and Watson, S. J. 1991. Differential distribution of D2 and D4 dopamine receptor mRNAs in the rat brain: An in situ hybridization study. Soc. Neurosci. Abstr. 17:599.Google Scholar
  14. 14.
    O'Malley, K. L., Harmon, S., Tang, L., and Todd, R. D. 1992. The rat D4 dopamine receptor: Sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biologist 4:137–146.Google Scholar
  15. 15.
    Meador-Woodruff, J. H., Grandy, D. K., Van Tol, H. H. M., Damask, S. P., Little, K. Y., Civelli, O., and Watson, S. J. 1994. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology 10:239–248.Google Scholar
  16. 16.
    Matsumoto, M., Hidaka, K., Tada, S., Tasaki, Y., and Yamaguchi, T. 1995. Full-length cDNA cloning and distribution of human dopamine D4 receptor. Mol. Brain Res. 29:157–162.Google Scholar
  17. 17.
    Meador-Woodruff, J. H., Damask, S. P., Wang, J., Haroutunian, V., Davis, K., and Watson, S. J. 1996. Dopamine receptor mRNA espression in human striatum and neocortex. Neuropsychopharmacology 15:17–29.Google Scholar
  18. 18.
    Kahn, R. S., and Davis, K. L. 1995. New developments in dopamine and schizophrenia. Pages 1193–1203, in Bloom, F. E., and Kupfer, D. J., (eds.), Psychopharmacology: The fourth generation of progress. Raven Press, Ltd., New York.Google Scholar
  19. 19.
    Meltzer, H. Y. 1995. Atypical antipsychotic drugs. Pages 1277–1286, in Bloom, F. E., and Kupfer, D. J., (eds.), Psychopharmacology: The fourth generation of progress. Raven Press, Ltd., New York.Google Scholar
  20. 20.
    Seeman, P., Guan, H-C., and Van Tol, H. H. M. 1993. Dopamine D4 receptors elevated in schizophrenia. Nature 365:441–445.Google Scholar
  21. 21.
    Seeman, P., Guan, H-C., Van Tol, H. H. M., and Niznik, H. B. 1993. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse 14:247–253.Google Scholar
  22. 22.
    Sumiyoshi, T., Stockmeier, C. A., Overholser, J. C., Thompson, P. A., and Meltzer, H. Y. 1995. Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmorten caudate nucleus of subjects with schizophrenia or major depression. Brain Res. 681:109–116.Google Scholar
  23. 23.
    Reynolds, G. P., and Mason, S. L. 1994. Are striatal dopamine D4 receptors increased in schizophrenia? J. Neurochem. 63:1576–1577.Google Scholar
  24. 24.
    Baskin, D. G., and Dorsa, D. M. 1986. Quantitative autoradiography and in vitro radioligand binding. Exp. Biol. Med. 11:204–234.Google Scholar
  25. 25.
    Kuhar, M. J. 1986. Quantitative receptor autoradiography: An overview. Pages 1–12, in Boast, C. A., Snowhill, E. W., Altar, C. A. (eds.), Quantitative receptor autoradiography, Chapter 1. Alan R. Liss, Inc. New York.Google Scholar
  26. 26.
    Murray, A. M., Hyde, T. M., Knable, M. B., Herman, M. M., Bigelow, L. B., Carter, J. M., Weinberger, D. R., and Kleinman, J. E. 1995. Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J. Neurosci. 15:2186–2191.Google Scholar
  27. 27.
    Lahti, R. A., Roberts, R. C., and Tamminga, C. A. 1995. D2-family receptor distribution in human postmorten tissue: an autoradiographic study. Neuroreport 6:2505–2512.Google Scholar
  28. 28.
    Baskin, D. G., Filuk, P. E., and Stahl, W. L. 1989. Standardization of tritium sensitive film for quantitative autoradiography. J. Histochem. Cytochem. 37:1337–1344.Google Scholar
  29. 29.
    Baskin, D. G., and Stahl, W. L. 1993. Fundamentals of quantitative autoradiography by computer densitometry for in situ hybridization with emphasis on 33P. J. Histochem. Cytochem. 41:1767–1776.Google Scholar
  30. 30.
    Antonelli, M. C., Baskin, D. G., Garland, M., and Stahl, W. L. 1989. Localization and characterization of binding sites with high affinity for [3H]Ouabain in cerebral cortex of rabbit brain using quantitative autoradiography. J. Neurochem. 52:193–200.Google Scholar
  31. 31.
    Stahl, W. L., and Baskin, D. G. 1990. Histochemistry of ATPases. J. Histochem. Cytochem. 38:1099–1122.Google Scholar
  32. 32.
    Maki, A. A., Baskin, D. G. and Stahl, W. L. 1992. [3H]-Ouabain binding sites in rat brain: Distribution and properties assessed by quantitative autoradiography. J. Histochem. Cytochem. 40:771–779.Google Scholar
  33. 33.
    Herkenham, M., and Sokoloff, L. 1984. Quantitative receptor autoradiography: tissue defatting eliminates differential self-absorption of tritium radiation in gray and white matter of brain. Brain Res. 321:363–368.Google Scholar
  34. 34.
    Geary, W. A., and Wooten, G. F. 1985. Regional tritium quenching in quantitative autoradiography of the central nervous system. Brain Res. 336:334–336.Google Scholar
  35. 35.
    Defagot, M. C., Malchiodi, E. L., Villar, M. J., and Antonelli, M. C. 1997. Distribution of D4 dopamine receptor in rat brain with sequence specific antibodies. Mol. Brain Res. (in press).Google Scholar
  36. 36.
    Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R., and Goldman-Rakic, P. S. 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245–248.Google Scholar
  37. 37.
    Amaral, D. G., and Witter, M. P. 1995. Hippocampal formation. Pages 443–493, in Paxinos, G., (ed.) The rat nervous system. 2nd ed., Academic Press. San DiegoGoogle Scholar
  38. 38.
    Heimer, L., Zahm, D. S., and Alheid, G. F. 1995. Basal Ganglia. Pages 579–628, in Paxinos, G., (ed). The rat nervous system. 2nd ed., Academic Press. San Diego.Google Scholar
  39. 39.
    Mansour, A., and Stanley, J. W. 1995. Dopamine receptor expression in the central nervous system. Pages 207–219, in Eloom, F. E. and Kupfer, D. J., (eds.), Psychopharmacology: The fourth generation of progress. Raven Press, Ltd., New York.Google Scholar
  40. 40.
    Holstege, G. 1995. The basic, somatic, and emotional components of the motor system in mammals. Pages 137–154 in Paxinos, G., (ed.) The rat nervous system. 2nd ed. Academic Press. San Diego.Google Scholar
  41. 41.
    Cox, R. F., and Waszczak, B. L. 1991. Autoradiography of dopamine D2 receptors using [3H] YM-09151–2. Eur. J. Pharmacol. 199:103–106.Google Scholar
  42. 42.
    Terai, M., Hidaka, K., Nakamura, Y. 1989. Comparison of [3H]YM-09151–2 with [3H]spiperone and [3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur. J. Pharmacol. 173:177–182.Google Scholar
  43. 43.
    Farooqui, S. M., Brock, J. W., Hamdi, A., and Prasad, C. 1991. Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. J. Neurochem. 57:1363–1369.Google Scholar
  44. 44.
    Vile, J. M., D'Souza, U. M., and Strange P. G. 1995. [3H]Nemonapride and [3H]Spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions. J. Neurochem. 64:940–943.Google Scholar
  45. 45.
    Kohler, C., Hall, H., Ogren, S-O., and Gawell, L. 1985. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopmine D-2 receptors in the rat brain. Biochem. Pharmacol. 34:2251–2259.Google Scholar
  46. 46.
    Assié, M. B., Sleight, A. J., and Koek, W. 1993. Biphasic displacement of [3H]YM-09151–2 binding in the rat brain by thioridazine, risperidone and clozapine, but not other antipsychotics. Eur. J. Pharmacol. 237:183–189.Google Scholar
  47. 47.
    Leysen, J. E., Eens, A., Gommeren, W., Van Gompel, P., Wynants, J., and Janssen, P. A. J. 1988. Identification of nonserotonergic [3H] ketanserin binding sites associated with nerve terminals in rat brain and with platelets relation with release of biogenic amine metabolites induced by ketanserin-and tetrabenazine-like drugs. J. Pharmacol. Exper. Ther. 244:310–321.Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • M. Cristina Defagot
    • 1
  • Marta C. Antonelli
    • 1
  1. 1.Instituto de Química y Fisicoquímica Biológicas (UBA-CONICET). Facultad de Farmacia y BioquímicaUniversidad de Buenos AiresBuenos AiresArgentina

Personalised recommendations